Mitoxantrone Hydrochloride Liposomes in Combination With GDP in Relapsed/Refractory PTCL

Clinical trial NCT05441761 · UNKNOWN

Trial details

NCT number: NCT05441761
Sponsor: Peking Union Medical College Hospital
Status: UNKNOWN
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Treatment Peripheral T-cell Lymphoma

Start date: 2022-05-01
Primary completion: 2025-05-01
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.